Spectral Computed Tomography or Spectral CT is emerging as a standard part of CT imaging. This, new generation CT solution allows clinicians to characterize tumors with greater certainty in comparison with the conventional CT scans that provide black and white images. This spectral detector-based CT also provides clinicians with the in-depth spectral information on demand, allowing them to analysis retrospectively at low-dose, which benefits patients. The state-of-the-art imaging systems complemented by a full suite of Spectral CT healthcare informatics solutions, support confident diagnosis, and personalized treatment.
The Spectral Computed Tomography (CT) Market trends report anticipates the industry size to reach USD 7822.35 Million by 2030 at 1.38% CAGR during the forecast period 2022-2030.
Spectral Computed Tomography (as instruments and technology) perceives a substantial demand, witnessing widespread installs at various HC infrastructures. Moreover, increasing prevalence of cardiac diseases, cancer, neurological disorders, orthopedic diseases, and many others are escalating the market on the global heights. As a result, the market for Spectral CT is burgeoning rapidly.
Acknowledging the kind of growth this market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the booming market of Spectral Computed Tomography is expected witness significant growth by 2030.
As per the statics provided by the National Institutes of Health, the number of patients older than 65 years undergoing diagnostic imaging is over two times more than the youngsters. Furthermore, factors such as technological advancements in the medical imaging devices, demand for advanced diagnosis equipment, and rising geriatric population, worldwide provide impetus to the market growth of spectral CT.
On the other hand, disseminating clinical information, studies, trials and healthcare news by social media the CT scans may increase the risk of brain cancer or other complications are impeding the market growth of Spectral CT, hampering its image and hence, its uptake in the market. Simultaneously, similar innovations such as the emergence of Revolutionary 3D color X-ray are affecting the market growth of Spectral CT.
Nevertheless, favorable reimbursement processes that the Spectral CT is gaining momentum with is expected to support the market growth throughout the assessment period.
Global Spectral Computed Tomography Market – Segmentations
MRFR has segmented its analysis into four key dynamics for an easy grasp;
By Types : Spiral CT, Electron Beam Tomography, Multi-Slice Computed Tomography, Positron Emission Tomography (PET), and Single-Photon Emission Computed Tomography among others.
By Applications : Oncology, Neurology, Cardiology, Spine, Musculoskeletal Disorders, Body Imaging, and Gastrointestinal Diseases among others.
By End Users : Diagnostic Centers and Hospitals among others.
By Regions : North America, Europe, APAC, and the Rest-of-the-World.
Global Spectral Computed Tomography Market – Geographical Analysis
The North American region dominates the global Spectral CT market with the significant market share. Factors like the growing prevalence of cancer, cardiovascular and neurological disorders, rising geriatric population, and the presence of a well-developed healthcare sector, are driving the market growth.
Moreover, increasing demand for technologically advanced treatment and diagnosis devices along with high health care expenditures, and government support are fostering the market growth in the region. Also, the presence of the leading manufacturers of spectral CT devices in the region is a predominant factor propelling the market growth.
The European region stands at the second position, in terms of the market share. The European market is expected to demonstrate healthy growth during the review period attributing to the factors such as the availability of advent & advanced treatment facilities & healthcare expenditures along with the growing demand for better healthcare infrastructure.
Moreover, factors such the rising cases of cancer and heart-related disorders along with the growing population that is increasingly adopting the sedentary lifestyle; are driving the market growth in the region. Constant funding support from the private and public bodies for R&D activities is propelling the growth of the Spectral CT market in the European region.
The Spectral CT market in the Asia Pacific region is emerging as a lucrative market that is expected to grow rapidly over the forecast period. Factors such as growing incidences of cancer and neurological disorders coupled with the availability of advanced diagnostic centers and the growing population that is increasingly gaining awareness towards good healthcare drive the market in the region.
Global Spectral Computed Tomography Market – Competitive Analysis
Spectral CT market appears to be competitive & fragmented owing to the presence of several matured & small key players forming a competitive landscape. Strategic partnership, expansion, acquisition, product & technology launch, and collaboration remain the key strategies of market players to achieve competitive advantage.
Some of the eminent players holding the Spectral Computed Tomography Market share include Agilent Technologies (US), Thermo Fisher Scientific (US), Koninklijke Philips N.V. (Netherlands), General Electric Company (US), Neusoft Medical Systems (Russia), Pall Corporation (US), Xoran Technologies, LLC (US), Hitachi medical corporation (Japan), Varian Medical Systems, Inc. (US), Siemens Healthcare Private Limited (Germany), Trivitron Healthcare (US), PerkinElmer Inc. (US), Cleaver Scientific Ltd (UK), Bio-Rad Laboratories, Inc. (US), NeuroLogica Corp (US), iCAD Inc. (US), Shenzhen Anke High-tech Co., Ltd. (China), and Shimadzu Corporation. (Japan).
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)